Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

Condition:   Ovarian Cancer Intervention:   Combination Product: 211-astatine MX35 F(ab')2 Sponsors:   Vastra Gotaland Region;   Swedish Cancer Society;   The Swedish Research Council;   Sahlgrenska University Hospital, Sweden Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials